Patent US4888423A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4888423A Expired / Lapsed US ⏱️ 0.0 years remaining

6-(4-Hydroxyphenyl)-4,5-dihydro-3(2h)-pyridazinones and stabilized compositions

Assignee: Novartis Corp
•
Filing: 1986-10-06
•
Granted: 1989-12-19
•
Expires: 2006-10-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 6-(4-hydroxyphenyl)-4,5-dihydro-3(2H)-pyridazinones of formula I <IMAGE> (I) where R1 and R2 are independently alkyl, cycloalkyl, aryl or aralkyl, R3 and R4 are independently hydrogen or alkyl, n is 1 to 4 and T is hydrogen, alkyl, substituted alkyl, alkylene or arylene, are effective in stabilizing organic materials against oxidative, thermal and actinic degradation.

Inventors

  • 👤 Paul A. Odorisio
  • 👤 Steven D. Pastor

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 15:08
CPC Classifications
C; C08; C08K; C08K5/00; C08K5/16; C08K5/34; C08K5/3442; C08K5/3462; C07; C07D; C07D237/00; C07D237/02; C07D237/04

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 42 words
A compound of formula Ia or Ib ##STR4## wherein R 1 and R 2 are each tert-butyl, R 3 and R 4 are each hydrogen, T is hydrogen, phenyl, 2-hydroxyethyl or 2-bromoethyl, and E is alkylene of 4 to 8 carbon atoms.
Claim 2
Dependent Claim 42 words
A compound of formula Ia or Ib ##STR4## wherein R 1 and R 2 are each tert-butyl, R 3 and R 4 are each hydrogen, T is hydrogen, phenyl, 2-hydroxyethyl or 2-bromoethyl, and E is alkylene of 4 to 8 carbon atoms.
Claim 3
Dependent Claim 10 words
The compound according to claim 1 which is bis-2,2'[6-(3,5-di-tert-butyl-4hydroxyphenyl)-4,5-dihydro-3(2H)-pyridazin-2-yl[-ethyl adipate.
Claim 4
Dependent Claim 9 words
The compound according to claim 1 which is 2-(2-bromoethyl)-6-(3,5-di-tert-butyl-4-hydroxyphenyl)-4,5-di-hydro-3(2H)-pyridazinone.
Claim 5
Dependent Claim 9 words
The compound according to claim 1 which is 6-(3,5-di-tert-butyl-4-hydroxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
Claim 6
Dependent Claim 9 words
The compound according to claim 1 which is 6-(3,5-di-tert-butyl-4-hydroxyphenyl)-4,5-dihydro-2-phenyl-3(2H)-pyridazinone.
Claim 7
Dependent Claim 9 words
The compound according to claim 1 which is 6-(3,5-di-tert-butyl-4-hydroxyphenyl)-4,5-dihydro-2-(2-hydroxyethyl)-3(2H)-pyridazinone.
Claim 8
Dependent Claim 10 words
The compound according to claim 1 which is bis-2,2'-[6-(3,5-di-tert-butyl-4-hydroxyphenyl)-4,5-di-hydro-3(2H)-pyridazin-2-yl]ethyl sebacate.

References Cited (Backward Citations)

US3377154A Cited
US4011321A Cited
US4397854A Cited
EP0178189A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-12-18 1993-06-19 1993-12-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-12-18 1997-06-19 1997-12-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-12-18 2001-06-19 2001-12-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag